Analyzing UV-B narrowband solar irradiance: comparison with erythemal and vitamin D production irradiances.

J Photochem Photobiol B

Departament d'Astronomia i Meteorologia, Universitat de Barcelona, Martí i Franquès 1, E-08028 Barcelona, Spain.

Published: December 2012

The heliotherapy and the phototherapy are mainly focused on taking benefit of the therapeutic effects of the ultraviolet (UV) irradiance on different skin diseases. The use of UV-B narrowband lamps, with emissions centered at 311 nm, has spread out among the dermatologist community because of its high therapeutic effect in comparison with its low erythema dose. For cloudless sun exposure, the balance of solar erythemal and solar narrowband (NB)-equivalent irradiances depends on several factors such as the solar zenith angle (SZA), the total ozone column (TOC) and the altitude. For SZA below 55°, the ratio of solar UV-B narrowband and erythemal irradiances increases with the SZA whereas the ratio of vitamin D production and erythemal irradiances decreases with the SZA with the maximum around midday. Furthermore, the solar NB ratio also increases with the TOC because the shorter wavelengths of the erythemal action spectrum are more affected by the ozone absorption processes. Considering the daily variations of the ratio between narrowband and erythemal irradiance, sun exposures avoiding midday hours are recommended in order to prevent negative side-effects. However to accumulate great NB doses and sufficient vitamin D in winter months is difficult because the time exposures may be longer than the day duration.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jphotobiol.2012.09.004DOI Listing

Publication Analysis

Top Keywords

uv-b narrowband
12
vitamin production
8
narrowband erythemal
8
erythemal irradiances
8
solar
6
erythemal
6
narrowband
5
analyzing uv-b
4
narrowband solar
4
solar irradiance
4

Similar Publications

Background: Vitiligo is a chronic autoimmune disease manifested by depigmented patches of skin devoid of melanocytes. Baricitinib, a JAK inhibitor selectively targeting JAK1/2, has shown preliminary efficacy for vitiligo. We aimed to assess the efficacy and tolerability of combination therapy with baricitinib and narrowband UV-B (NB-UVB) to treat active nonsegmental vitiligo (NSV).

View Article and Find Full Text PDF
Article Synopsis
  • The study compares the effectiveness of home-based vs. office-based phototherapy for psoriasis, highlighting that while office therapy is cost-effective, it’s often hard to access compared to the more patient-preferred home therapy, which lacks sufficient clinical data, especially for those with darker skin.
  • Conducted across 42 dermatology practices in the US, the trial involved 783 participants aged 12 and older with psoriasis, who were randomly assigned to either home or office phototherapy for 12 weeks, followed by another 12 weeks of observation.
  • Results showed that home phototherapy led to better skin clearance and quality of life improvements, with 32.8% of participants achieving clear skin compared to
View Article and Find Full Text PDF

Apart from the use of sun therapy for the cure of many skin diseases and disorders of bygone days, nowadays artificial light sources of a narrowband (NB) ultraviolet-B (UV-B) have effectively revolutionized the treatment of such skin diseases. The crucial role of gadolinium (Gd) ions in calcium-based hosts lies in their narrowband emission spectrum, specifically at 311-315 nm, attributed to the P to S transition. Calcium-based materials, known for their chemical stability, facilitate Gd embedding, enabling UV activation and express emission in the narrowband range.

View Article and Find Full Text PDF
Article Synopsis
  • Generalized lichen planus (GLP) is a chronic skin condition affecting about 1% of the population and has limited research compared to other types like oral lichen planus; this study aimed to find effective steroid-sparing treatments.* -
  • The study involved 90 patients who were treated with systemic steroids and one of three therapies (azathioprine, dapsone, or narrowband UV-B) over 16 weeks, measuring itch severity and quality of life at baseline and 24 weeks.* -
  • Results showed that narrowband UV-B had the best overall improvement in itching and quality of life, with significant differences in treatment effectiveness compared to azathioprine and dapsone, and both
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!